10Jul
Proactive Due Diligence Considerations for Life Sciences Dealmakers
In today’s competitive and fast-paced life sciences dealmaking environment, buyers and investors are often unable to spend as much time on due diligence as they might like. Market players are often highly focused on the science itself and, as a...
By:
McDermott Will & Emery
Related
Despite unprecedented disruptions to the court system from the COVID-19 pandemic, plaintiffs continu...
Read More >
Dos Toros - Maintaining Culture While Scaling (and Having Fun) Matt Steinberg welcomes Dos Toros’ ...
Read More >
Distressed companies can be attractive acquisition targets, as their values often reflect the diffic...
Read More >
There is perhaps no more consistently vexing problem for transactional attorneys on opposite sides t...
Read More >
Despite a slight drop in workplace sexual harassment cases in Fiscal Year 2019, the amount of the se...
Read More >
December 2019 brought significant changes to the National Labor Relations Board (NLRB) case law and ...
Read More >